pharma
TORAY INTERNATIONAL U.K
Toray International U.K. Limited
Toray International U.K is a pharma organization headquartered in GB. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USP
Company details
- Status
- Public
- HQ
- GB
- Employees
- 2
- Programs
- 1
- Drugs
- 8
- Patents
- 0
950P1V02
Phase 1 · other · Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor
950P1V02 for Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor is a Phase 1 program (other) at Toray International U.K. Limited with 1 ClinicalTrials.gov record(s).
Internal code 950P1V02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Toray International U.K. Limited
- Phase
- Phase 1
- Modality
- other
- Indication
- Bladder cancer, Cholangiocarcinoma, Colorectal Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Gastric Cancer, Melanoma, Ovarian Cancer, Palpable Subcutaneous Malignant Lesions, Primary Peritoneal Cancer, Renal Cell Carcinoma, Solid Tumor
- Status
- active
- Trials
- 1